How much funding has iNova Pharmaceuticals raised?

iNova Pharmaceuticals has raised $2.3B in total funding, most recently a Private Equity round.

Who are iNova Pharmaceuticals's investors?

iNova Pharmaceuticals's investors include TPG (Growth/Rise), Pacific Capital Management, Abu Dhabi Investment Authority, The Carlyle Group.

When was iNova Pharmaceuticals founded?

iNova Pharmaceuticals was founded in 2006.

Where is iNova Pharmaceuticals headquartered?

iNova Pharmaceuticals is headquartered in Sydney, Australia.

What industry is iNova Pharmaceuticals in?

iNova Pharmaceuticals operates in Healthcare.

How many employees does iNova Pharmaceuticals have?

iNova Pharmaceuticals has 201-500 employees.

iNova Pharmaceuticals

Leading the way to better health

Sydney, Australia · Founded 2006 · $2.3B raised

Healthcare

Headquarters: Sydney
Employees: 201–500
Founded: 2006
Business Model: B2B2C

Website: inovapharma.com
Total Funding: $2.3B
Last Round: $1.4B Private EquityOct 2022
Rounds: 2

About

iNova Pharmaceuticals is a consumer health company that develops and markets a portfolio of market-leading OTC brands and prescription medicines across therapeutic areas including throat, cough, cold and flu, wound care, skin care, pain management, and weight management. Operating with speed and agility, iNova delivers science-backed health solutions to consumers across multiple geographies.

Summary

iNova Pharmaceuticals is a Healthcare company based in Sydney, Australia, founded in 2006. It has raised $2.3B in total across 2 rounds, most recently a $1.4B Private Equity round in Oct 2022. Investors include TPG (Growth/Rise), Pacific Capital Management and Abu Dhabi Investment Authority.

LinkedIn X (Twitter)